210 related articles for article (PubMed ID: 34751593)
1. Diagnostic and prognostic value of
Wang MQ; Yin QY; Chen YR; Zhu SL
Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
[TBL] [Abstract][Full Text] [Related]
2. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer.
Luo S; Lin R; Liao X; Li D; Qin Y
Sci Rep; 2021 Dec; 11(1):23674. PubMed ID: 34880371
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic analyses of HDACs in human gastric cancer based on bioinformatic analysis.
Chen L; Fei Y; Zhao Y; Chen Q; Chen P; Pan L
Medicine (Baltimore); 2021 Jul; 100(27):e26554. PubMed ID: 34232196
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
7. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
8. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
10. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer.
Dong Y; Li X; Lin Z; Zou W; Liu Y; Qian H; Jia J
J Exp Clin Cancer Res; 2019 Dec; 38(1):502. PubMed ID: 31870402
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM
Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
Guo Y; He Y
Sci Rep; 2020 Oct; 10(1):18352. PubMed ID: 33110097
[TBL] [Abstract][Full Text] [Related]
13. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
Fei HJ; Chen SC; Zhang JY; Li SY; Zhang LL; Chen YY; Chang CX; Xu CM
Int J Oncol; 2018 Mar; 52(3):955-966. PubMed ID: 29328368
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
15. Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer.
Xu J; Wang X; Ke Q; Liao K; Wan Y; Zhang K; Zhang G; Wang X
Sci Rep; 2021 Jul; 11(1):15412. PubMed ID: 34326374
[TBL] [Abstract][Full Text] [Related]
16. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1.
Zhang E; He X; Zhang C; Su J; Lu X; Si X; Chen J; Yin D; Han L; De W
Genome Biol; 2018 Oct; 19(1):154. PubMed ID: 30286788
[TBL] [Abstract][Full Text] [Related]
17. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
Zhao W; Wang Y; Yue X
Future Oncol; 2018 Sep; 14(21):2139-2148. PubMed ID: 29698084
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
19. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
20. Increased HOXC6 mRNA expression is a novel biomarker of gastric cancer.
Jung J; Jeong S; Jeong H; Oh HE; Choi JW; Lee ES; Kim YS; Kwak Y; Kim WH; Lee JH
PLoS One; 2020; 15(8):e0236811. PubMed ID: 32745141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
